Cite
Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance).
MLA
Klepin, Heidi D., et al. “Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance).” Journal of Oncology Practice, vol. 10, no. 5, Sept. 2014, pp. e285–92. EBSCOhost, https://doi.org/10.1200/JOP.2014.001388.
APA
Klepin, H. D., Pitcher, B. N., Ballman, K. V., Kornblith, A. B., Hurria, A., Winer, E. P., Hudis, C., Cohen, H. J., Muss, H. B., & Kimmick, G. G. (2014). Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance). Journal of Oncology Practice, 10(5), e285–e292. https://doi.org/10.1200/JOP.2014.001388
Chicago
Klepin, Heidi D., Brandelyn N. Pitcher, Karla V. Ballman, Alice B. Kornblith, Arti Hurria, Eric P. Winer, Clifford Hudis, Harvey J. Cohen, Hyman B. Muss, and Gretchen G. Kimmick. 2014. “Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance).” Journal of Oncology Practice 10 (5): e285–92. doi:10.1200/JOP.2014.001388.